Literature DB >> 18055340

Dilated cardiomyopathy during the course of hemolytic uremic syndrome.

Alexandra Alexopoulou1, Spyros P Dourakis, Christos Zovoilis, Emmanouel Agapitos, Aris Androulakis, Anna Filiotou, Athanasios J Archimandritis.   

Abstract

A 47-year-old woman presented with severe hemolytic uremic syndrome (HUS) followed by heart failure. An echocardiogram showed an ejection fraction of 20%, and a cardiac catheterization followed by a myocardial histologic evaluation demonstrated dilated cardiomyopathy. Plasma exchange and hemodialysis were performed regularly. The later outcomes of renal function and cardiomyopathy were favorable. A review of the literature confirmed the rare and severe nature of cardiac lesions occurring in the course of HUS. This case indicates the importance of cardiac monitoring in HUS and the need for prolonged support.

Entities:  

Mesh:

Year:  2007        PMID: 18055340     DOI: 10.1532/IJH97.E0713

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  13 in total

1.  Sudden cardiac death from thrombotic thrombocytopenic purpura.

Authors:  T Wajima; E H Johnson
Journal:  Clin Appl Thromb Hemost       Date:  2000-04       Impact factor: 2.389

Review 2.  Massive myocardial necrosis in thrombotic thrombocytopenic purpura: a case report and review of the literature.

Authors:  S H Podolsky; A Zembowicz; F J Schoen; R J Benjamin; L A Sonna
Journal:  Arch Pathol Lab Med       Date:  1999-10       Impact factor: 5.534

3.  Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands.

Authors:  C M Taylor; R H White; M H Winterborn; B Rowe
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-07

4.  A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the Southwest Pediatric Nephrology Study Group.

Authors:  J C Argyle; R J Hogg; T J Pysher; F G Silva; R L Siegler
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

5.  Myocarditis and myocardial hemorrhage associated with thrombotic thrombocytopenic purpura.

Authors:  J G Webb; J Butany; G Langer; G Scott; P P Liu
Journal:  Arch Intern Med       Date:  1990-07

6.  Myocarditis and haemolytic uraemic syndrome.

Authors:  I Abu-Arafeh; E Gray; G Youngson; I Auchterlonie; G Russell
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

7.  The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients.

Authors:  R L Ridolfi; G M Hutchins; W R Bell
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

8.  Thrombocytopenic purpura and cardiomyopathy in pregnancy reversed by combined plasma exchange and infusion.

Authors:  Elizabeth M Cosmai; Leopold Puzis; H-M Tsai; Eric C-Y Lian
Journal:  Eur J Haematol       Date:  2002-04       Impact factor: 2.997

9.  Dilated cardiomyopathy associated with haemolytic uraemic syndrome.

Authors:  J Poulton; C M Taylor; J V De Giovanni
Journal:  Br Heart J       Date:  1987-02

Review 10.  Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome.

Authors:  E G Gallo; C A Gianantonio
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

View more
  4 in total

1.  Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review.

Authors:  Melody Hermel; David Hermel; Saif Azam; Jerold Shinbane; Annahita Sarcon; Erika Jones; Arjun Mehta; Luanda Grazette; Howard Liebman; Ilene Weitz
Journal:  EJHaem       Date:  2020-07-31

2.  Atypical haemolytic uraemic syndrome: a case report of a rare cause of reversible cardiomyopathy.

Authors:  Courtney M Campbell; Clarissa Cassol; Spero R Cataland; Rami Kahwash
Journal:  Eur Heart J Case Rep       Date:  2020-03-12

3.  Severe left ventricular systolic dysfunction in a patient with a typical haemolytic-uraemic syndrome treated with rituximab-coincidence or cause?

Authors:  Colin J Petrie; Robin A P Weir; Mitchell M Lindsay; Neal Padmanabhan; Kenny Douglas
Journal:  NDT Plus       Date:  2010-04-09

4.  A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.

Authors:  Lubka T Roumenina; Marie Frimat; Elizabeth C Miller; Francois Provot; Marie-Agnes Dragon-Durey; Pauline Bordereau; Sylvain Bigot; Christophe Hue; Simon C Satchell; Peter W Mathieson; Christiane Mousson; Christian Noel; Catherine Sautes-Fridman; Lise Halbwachs-Mecarelli; John P Atkinson; Arnaud Lionet; Veronique Fremeaux-Bacchi
Journal:  Blood       Date:  2012-01-13       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.